nurodot
Advancing Clinical Trials with AI

Transforming Alzheimer's Trials with Digital Twins

Our AI-powered platform conducts remote cognitive assessments through voice analysis, generates digital patient twins for clinical trial optimization, and provides real-time biomarker tracking for Alzheimer's research and drug development.

The Critical Challenges in Alzheimer's Clinical Trials

Traditional approaches are failing, leading to immense costs, delays, and missed opportunities for millions.

Protracted Timelines

With a 99.6% failure rate and $2-3 billion cost per failed drug, trials average 10-15 years, delaying vital treatments.

Patient Recruitment

Up to 80% of clinical trials face delays due to recruitment issues, with high dropout rates (often over 30%) and limited diversity impacting study validity.

Sparse Data

Infrequent, subjective assessments capture less than 1% of daily cognitive fluctuations, resulting in incomplete data.

Cognitive Bottlenecks

In-person cognitive tests cost thousands per patient annually, requiring specialized sites and limiting scalability.

Our Approach

Digital Twins & Voice AI: Precision Medicine

nurodot integrates AI to create a paradigm shift in Alzheimer's research and treatment.

Voice-Based Cognitive Testing

Automated, conversational AI administers standardized cognitive assessments, capturing rich speech biomarkers and precise cognitive performance metrics remotely.

Predictive Digital Patient Twins

Generate dynamic virtual patient models that simulate disease progression, predict treatment responses, and optimize clinical trial design with unparalleled accuracy.

Intelligent Analytics Dashboard

A comprehensive platform offering real-time patient enrollment tracking, advanced biomarker visualization, and predictive analytics for data-driven clinical decision-making.

Voice AI
Digital Twins
Insights
Advanced Cognitive Assessment

Transforming Cognitive Testing: Traditional vs. nurodot AI

See how nurodot's Voice AI overcomes the critical limitations of conventional cognitive assessments.

Facilities & Accessibility

Traditional: Site-Dependent

Requires in-person visits to specialized clinical sites, limiting patient access and increasing logistical burden.

nurodot: Remote & Accessible

Assessments conducted remotely via telephone or computer, increasing global patient reach.

Frequency & Data Richness

Traditional: Infrequent Snapshots

Assessments only every 3-6 months, missing subtle, real-time changes in disease progression.

nurodot: Continuous Monitoring

Daily or weekly assessments capture continuous, granular data on disease progression in real-time.

Cost & Scalability

Traditional: High & Limited

Expensive to scale across diverse patient populations, creating significant operational and cost hurdles.

nurodot: Cost-Effective & Scale

Test thousands of patients simultaneously across global populations, enabling large-scale studies efficiently.

Objectivity & Precision

Traditional: Subjective & Variable

Human interpretation introduces variability and bias, impacting data consistency and reliability.

nurodot: Objective & Precise

AI analysis eliminates human bias with consistent, quantifiable results, improving data integrity and reliability.

Voice Biomarkers: Uncovering Hidden Patterns
Speech Fluency

Pause patterns, speech rate, articulation nuances

Semantic Memory

Word retrieval, category fluency, naming accuracy

Executive Function

Working memory, cognitive flexibility, planning

Language Processing

Syntax complexity, vocabulary richness, coherence

Comprehensive Platform

End-to-End Clinical Trial Management Suite

From intelligent patient recruitment to advanced data analysis, our platform streamlines every aspect of modern clinical trials.

Patient Enrollment & Management
  • Automated screening and eligibility assessment
  • Digital consent and streamlined onboarding workflows
  • Advanced patient engagement and retention tools
  • Real-time enrollment tracking and predictive analytics
Cognitive Assessment Suite
  • Automated MoCA (Montreal Cognitive Assessment)
  • Digital MMSE (Mini-Mental State Examination)
  • AI-powered Clock Drawing Test automation
  • Customizable voice biomarker protocols
Data Analytics & Insights
  • Real-time biomarker visualization dashboards
  • Advanced predictive modeling and forecasting
  • Robust statistical analysis and reporting tools
  • Automated regulatory compliance documentation

Transforming Clinical Outcomes

Our platform delivers measurable improvements across every aspect of clinical trial execution, driving efficiency and success.

Accelerated Enrollment

Streamline patient recruitment and screening with automated cognitive assessments and digital workflows, significantly reducing time-to-enrollment.

Enhanced Data Quality

Capture high-frequency, objective biomarker data with standardized protocols and automated analysis, leading to more robust and reliable insights.

Reduced Operational Costs

Lower trial costs through remote monitoring, automated assessments, and predictive patient modeling, optimizing resource allocation.

Scalable Remote Testing

Deploy cognitive assessments globally with consistent protocols and real-time data collection capabilities, expanding research reach.

Ready to Transform Your Clinical Trials?

Join leading pharmaceutical companies and research institutions using nurodot to accelerate Alzheimer's drug discovery and bring hope to millions.

Schedule a personalized demo. Privacy Policy